Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carlos Lahoz

Showing results (1-10 of 119) with videos related to

Pageof 12
Sort By:
Clinica E Investigacion En Arteriosclerosis : Publicacion Oficial De La Sociedad Espanola De Arteriosclerosis|December 7, 2024
New horizons in the treatment of hypercholesterolemiaCarlos Lahoz, Xavier Pintó
Journal of Investigational Allergology & Clinical Immunology|December 7, 2007
Trends in olive pollen allergy. IntroductionCarlos Lahoz, Fernando Florido
Revista Espanola De Cardiologia|March 7, 2007
[Atherosclerosis as a systemic disease]Carlos Lahoz, José M Mostaza
Medicina Clinica|June 8, 2006
[Tables for cardiovascular risk estimation: many questions remain]José M Mostaza, Carlos Lahoz
Medicina Clinica|November 6, 2003
[Can genes predict the response to treatment with statins?]Carlos Lahoz, José María Mostaza
Medicina Clinica|June 18, 2013
[New approaches for the treatment of dyslipidemia]José María Mostaza, Carlos Lahoz
Medicina Clinica|April 24, 2009
["New" cardiovascular risk factors: will they emerge or will go down?]José María Mostaza, Carlos Lahoz
Medicina Clinica|July 8, 2010
[Who should have the ankle-arm index measured?]José María Mostaza, Carlos Lahoz
Medicina Clinica|June 19, 2009
[HDL-cholesterol: from risk factor to therapeutic target]Carlos Lahoz, José M Mostaza
Clinica E Investigacion En Arteriosclerosis : Publicacion Oficial De La Sociedad Espanola De Arteriosclerosis|May 10, 2021
Main barriers in the management of dyslipidaemias: IntolerantsJosé María Mostaza, Carlos Lahoz
Pageof 12

Showing results (1-10 of 119) with videos related to

Sort By:
Pageof 12
Clinica E Investigacion En Arteriosclerosis : Publicacion Oficial De La Sociedad Espanola De Arteriosclerosis|December 7, 2024
New horizons in the treatment of hypercholesterolemiaCarlos Lahoz, Xavier Pintó
Journal of Investigational Allergology & Clinical Immunology|December 7, 2007
Trends in olive pollen allergy. IntroductionCarlos Lahoz, Fernando Florido
Revista Espanola De Cardiologia|March 7, 2007
[Atherosclerosis as a systemic disease]Carlos Lahoz, José M Mostaza
Medicina Clinica|June 8, 2006
[Tables for cardiovascular risk estimation: many questions remain]José M Mostaza, Carlos Lahoz
Medicina Clinica|November 6, 2003
[Can genes predict the response to treatment with statins?]Carlos Lahoz, José María Mostaza
Medicina Clinica|June 18, 2013
[New approaches for the treatment of dyslipidemia]José María Mostaza, Carlos Lahoz
Medicina Clinica|April 24, 2009
["New" cardiovascular risk factors: will they emerge or will go down?]José María Mostaza, Carlos Lahoz
Medicina Clinica|July 8, 2010
[Who should have the ankle-arm index measured?]José María Mostaza, Carlos Lahoz
Medicina Clinica|June 19, 2009
[HDL-cholesterol: from risk factor to therapeutic target]Carlos Lahoz, José M Mostaza
Clinica E Investigacion En Arteriosclerosis : Publicacion Oficial De La Sociedad Espanola De Arteriosclerosis|May 10, 2021
Main barriers in the management of dyslipidaemias: IntolerantsJosé María Mostaza, Carlos Lahoz
Pageof 12